جستجوی استاد راهنمای دانشگاهی

Lee Yong Limمشاهده پروفایل

استاد

• Drug Delivery Systems
• Pediatric Medicinal Products
• Taste-Masked Medicines
• +۴ مورد دیگر

Lee Yong Lim is a Professor of Pharmaceutics at The University of Western Australia (UWA), leading the Laboratory for Drug Delivery. She specializes in innovative drug delivery systems, particularly for pediatric populations and marine aquaculture. Her work focuses on overcoming medication challenges for children through taste-masked formulations and stable drug-loaded scaffolds for ear diseases. She has secured over $4.5 million in research grants from diverse funding bodies. Education: BSc (Pharmacy) Hons, National University of Singapore PhD, University of Manchester Research: Her team developed a patented chocolate-based formulation for bitter drugs and conducts pediatric trials. Collaborations include WA hospitals for safe compounded medicines and international projects in nanotechnology. Key research areas include pediatric medicinal products, veterinary drug delivery, and sustainable drug formulations aligned with UN SDGs. Grants & Funding: Major supporters include NHMRC, ARC, Telethon, and industry partnerships. Current active grants focus on pre-procedural chewables for children and perioperative analytics. Labs/Teams: Heads the Laboratory for Drug Delivery and collaborates with the Centre for Optimisation of Medicines and Institute for Paediatric Perioperative Excellence.

Craig Russellمشاهده پروفایل

مدرس

• Pharmaceutical Formulation
• Drug Delivery Systems
• Nanotechnology in Pharmacy
• +۳ مورد دیگر

Craig Russell is a Lecturer in Pharmacy at Aston University, affiliated with the College of Health and Life Sciences and the Pharmaceutical & Clinical Pharmacy Research Group. He holds a PhD in Paediatric Drug Development from Aston University (2014) and a BSc in Human Biology from the University of Huddersfield (2010). His research focuses on pharmaceutical formulation design, 3D printing in drug manufacturing, nanoparticle drug delivery systems, and genomic approaches to drug development. He leads the MPharm Programme and teaches across multiple disciplines, including Cell Biology, Formulation Science, and Biopharmaceutics. Key projects include a funded PhD investigating 3D printing in tablet production (2018) and collaborations with major pharmaceutical companies like AstraZeneca and GSK. His work emphasizes translational research, bridging laboratory innovations with clinical applications. Recent studies explore mesoporous silica microparticles for targeted drug delivery and photopolymer resin optimization for Stereolithography. Education: BSc Human Biology (Huddersfield, 2010), PhD in Paediatric Drug Development (Aston, 2014), PG Cert HEA (2018). Teaching: MPharm Programme Director; lectures on Cell Biology, Immunology, and Formulation Science. Research Themes: Pharmaceutical Formulation, Nanotechnology, 3D Printing, Genomics. Grants: Internal funding for 3D printing in tablet production. Collaborations: AstraZeneca, GSK, Pfizer, Bristol Myers Squibb, UCL. His articles span drug delivery systems, 3D printing advancements, and genomic profiling, reflecting a commitment to innovation in pharmaceutical science.

Zahra Khanمشاهده پروفایل

مدرس ارشد

• Paediatric Nutrition
• Neonatal Nutrition
• Clinical Nutrition
• +۵ مورد دیگر

Dr. Zahra Khan serves as a Senior Lecturer in Human Nutrition & Health Science at the University of Greenwich within the School of Science and Faculty of Engineering and Science. With extensive international experience spanning clinical nutrition, public health research, and academic leadership across Pakistan, Oman, and Austria, she brings multidisciplinary expertise to advancing nutritional science and policy. Her academic credentials include: Undergraduate and Master's degrees in Food and Nutrition (Pakistan) M.Phil in Public Health and Preventive Medicine PhD with Distinction from Medical University of Graz, Austria (2013) Dr. Khan's research focuses on life-stage nutrition with particular emphasis on paediatric and neonatal health. Her clinical work at Children's Hospital Graz established foundational expertise in infant nutritional interventions, while her public health contributions in Pakistan address malnutrition treatment protocols, maternal nutrition strategy development, and adolescent dietary behavior change communication. She actively bridges clinical practice with national policy formulation through government technical committees. Her scholarly impact extends through international conference presentations and peer-reviewed publications in paediatric nutrition. Dr. Khan has served as academia resource person for provincial consultation meetings developing Pakistan's National Maternal Nutrition Strategy and National Adolescents' Nutrition Strategy, translating research into actionable public health frameworks. Dr. Khan mentors future nutrition professionals through curriculum development and teaching while maintaining active engagement with global nutrition initiatives. Her career reflects a consistent commitment to evidence-based interventions addressing malnutrition across the lifespan, particularly in vulnerable pediatric populations and underserved communities.

Connie Locherمشاهده پروفایل

دانشیار

• Natural Product Chemistry
• Phytochemical Analysis
• Western Australian Honeys
• +۵ مورد دیگر

Connie Locher is an Associate Professor at the University of Western Australia (UWA), affiliated with the School of Allied Health, Pharmacy UWA Medical School, and the Institute for Paediatric Perioperative Excellence. She holds a PhD in Natural Product Chemistry from Charles Darwin University and a Staatsexamen in Pharmacy from the University of Tübingen. Her research focuses on natural product chemistry, particularly the analysis of Western Australian honeys and traditional medicinal plants, as well as paediatric formulations and complementary medicines. Education: PhD in Chemistry, Northern Territory University (2000) Staatsexamen in Pharmacy, University of Tübingen (1995) Research interests include bioactive compound isolation, honey formulations for wound care, and the role of wellness in health communities. She is a core member of UWA’s Centre for Optimisation of Medicines and actively contributes to the Cooperative Research Centre for Honey Bee Products (CRC HBP). Notable awards include Excellence in Teaching Awards (2014, 2017) and grants totaling 11 projects, such as the CHIPMUNK initiative for paediatric drug formulations and studies on honey’s antibacterial properties. Her work aligns with UN Sustainable Development Goals related to health and well-being. Lab and team involvement includes collaborations in CRC HBP Program 2 and leadership in honey testing methodologies, contributing to 80+ research outputs and datasets.

• Gastroenterology
• Paediatrics
• Regenerative Medicine
• +۳ مورد دیگر

Dr. Conor McCann is a Lecturer in Paediatric Regenerative Medicine at University College London (UCL), affiliated with the Great Ormond Street Institute of Child Health and the Developmental Biology & Cancer Department. His research focuses on gastrointestinal tract development, enteric nervous system regeneration, and cell therapies for gut diseases. Education: PhD in Cellular and Molecular Pharmacology and Physiology (2010) from University of Nevada, Reno BSc (Hons) in Pharmacology and Pharmaceutical Sciences (2005) from Queen's University of Belfast His work emphasizes: Functional development of the gut Regenerative cell therapies Enteric nervous system stem cell transplantation Genetic and microenvironmental regulation of cellular fate Key research trends include: Stem cell applications in gut motility disorders Neural regeneration for Chagas disease and Hirschsprung's disease Developmental mechanisms in neuroepithelial structures Role of signaling pathways (e.g., Ret) in enteric neurogenesis Drug delivery systems for paediatric applications Scientific contributions: Guts UK Derek Butler Fellowship (2017) Principal Investigator status at UCL Leadership in the Gut Development and Repair Group Teaching activities: Co-Director of UCL MSc Cell & Gene Therapy program Lecturer for Molecular Aspects of Cell and Gene Therapy module Professional engagements: International Society for Stem Cell Research (2024) Physiological Society (2015) BSDB – British Society for Developmental Biology (2012) He co-leads the INSPIRE program promoting inclusive research education and contributes to the United Nations Sustainable Development Goals (3: Good Health, 4: Quality Education, 10: Reduced Inequalities).

Stefan Zimmerمشاهده پروفایل

استاد

• Caries prevention
• Non-carious dental hard-tissue defects
• Fluoride prophylaxis
• +۳ مورد دیگر

Prof. Dr. med. dent. Stefan Zimmer is Chair for Conservative and Preventive Dentistry and Head of the Department of Conservative and Preventive Dentistry at the University of Witten/Herdecke, Germany. Since 2021 he also serves as Dean of the Faculty of Health. His clinical and research activities centre on the prevention of caries and non-carious hard-tissue lesions, evidence-based fluoride programmes, occupational dental prevention and public-health implementation. Education & Academic Career 1988 – Dr. med. dent., Free University of Berlin 1994 – Specialist training (Fachzahnarzt) 2000 – Habilitation & Privatdozent, FU Berlin 2005 – Extraordinary Professor, Heinrich-Heine-University Düsseldorf 2008 – Full Professor & Chair, University of Witten/Herdecke 2021 – Dean, Faculty of Health, University of Witten/Herdecke Research Interests Prof. Zimmer’s work spans basic laboratory science , clinical intervention trials and public-health implementation research . Key themes include: Caries prevention through fluoride toothpastes, varnishes, salt and rinses Occupational dental prevention programmes in workplace settings Surface degradation and erosion from acidic beverages and bleaching agents Effectiveness of manual, sonic and powered oral-hygiene devices Development of evidence-based guidelines for vulnerable age groups (children, elderly, HIV patients) Scientific Awards Gesundheitspreis NRW (2015) Ehrenzeichen des Bundesverbandes der Zahnärzte im Öffentlichen Gesundheitswesen in Silber (1998) Tholuck Medaille der Gesellschaft für Zahnhygiene (2013) Gesundheitspreis NRW – 2nd place (2008) Hufeland-Preis (2006) Advising & Grants Prof. Zimmer currently mentors numerous doctoral and master’s students in clinical and public-health dentistry. His projects receive funding from the German Research Foundation, Federal Ministry of Health, European regional programmes and industry partners. He leads the interdisciplinary Research Group on Occupational Dental Prevention and coordinates several multi-centre clinical trials on fluoride delivery systems. Laboratories & Teams He directs the Laboratory for Preventive Dentistry and Public Health and is scientific director of the University Centre for Dental Prevention , which houses pre-clinical simulation units, microbiological and materials-testing labs, and a clinical trial outpatient clinic.

• Neonatal and Paediatric Pharmaceutics
• Drug Delivery Systems
• Parenteral Formulations
• +۴ مورد دیگر

Fiona O'Brien is a Senior Lecturer at the School of Pharmacy, Royal College of Surgeons in Ireland (RCSI). She specializes in Neonatal and Paediatric Pharmaceutics, with a focus on drug delivery systems, parenteral formulations, and patient safety in neonatal care. Her research involves collaborations with institutions like the Rotunda Maternity Hospital, Alder Hey Children’s Hospital, and Pfizer UK. She leads the Parenteral Formulations work stream for the European Paediatric Formulation Initiative (EuPFI). Education: PhD (Trinity College Dublin), MSc (Newcastle University), BSc (University College Dublin). Postdoctoral training at Trinity College Dublin. Certifications in Health Professions Education and Leadership. Research focuses on neonatal medication safety, parenteral nutrition compatibility, and co-designed drug information resources for parents. Key projects include the PADDINGToN feasibility study (NIHR/RCSI-funded) and compatibility studies of IV medications with TPN solutions. Teaching includes Immunology and Molecular Medicine modules. Grants include €1.2M from Pfizer and NIHR for formulation studies. Over 22 peer-reviewed publications since 2005, covering neonatal drug delivery, siRNA delivery systems, and pandemic education adaptations.

Maya Thanouمشاهده پروفایل

استاد

• Pharmaceutical Nanotechnology
• Theranostic Nanoparticles
• MRI/Guided Focused Ultrasound
• +۴ مورد دیگر

Maya Thanou is a Professor of Pharmaceutical Nanotechnology at King’s College London, based in the Institute of Pharmaceutical Science within the School of Cancer & Pharmaceutical Sciences. She holds a PhD from LACDR (Leiden/Amsterdam Centre for Drug Research) and has held academic roles at Cardiff University (Lecturer) and Imperial College London (via a Dorothy Hodgkin Royal Society Fellowship). Her research focuses on engineering image-guided drug delivery systems using nanoparticles and nanomaterials, with emphasis on theranostic applications, focused ultrasound, and MRI-guided therapies. Key areas include nanomaterials for microwave imaging, biocompatible quantum dots, and siRNA delivery. She collaborates with industry and holds 10 patents, co-editing an RSC book on theranostics. Awards include the AAPS Graduate Research Award (2000) and the Royal Society Fellowship (2004). Education: PhD in Pharmaceutical Sciences (LACDR, 2000) Key Roles: Director of MSc Pharmaceutical Technology Programme, Principal Investigator on multiple grants (EPSRC, BBSRC, CRUK, etc.) Research Themes: Theranostic nanoparticles for tumour treatment MRI/focused ultrasound drug delivery Nano-bio interface engineering Contrast agents for microwave imaging Her work spans 80+ publications and multiple collaborative projects, including recent initiatives on brain tumour drug delivery (Brain Tumour Charity-funded) and STING agonist immunotherapy for paediatric gliomas (CRUK-funded). She also co-founded Apeikon Therapeutics, a spinout from King’s focusing on nanomedicine innovations.

Priyia Pusparajahمشاهده پروفایل

دانشیار

• Medical Education
• Bioprospecting
• Microbiome Research
• +۷ مورد دیگر

Priyia Pusparajah is an Associate Professor at the Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia. She holds a medical degree from the University of Malaya and a Master’s in Paediatrics from the National University of Singapore. She joined Monash University in July 2012, transitioning from clinical paediatrics to a full-time academic career focused on medical education and research. Bachelor of Medicine and Bachelor of Surgery (MBBS), University of Malaya (1999–2004) Master of Paediatric Medicine (MMed), National University of Singapore (2008–2009) Dr. Pusparajah is a passionate medical educator with a strong focus on integrating foundational sciences with clinical practice. She coordinates key components of the medical curriculum including Physiology, Clinical Skills, and the interdisciplinary Concept Consolidation sessions that reinforce learning in pre-clinical years. Her research lies at the intersection of bioprospecting and microbiome science, particularly exploring natural substances from mangrove-derived Streptomyces for novel antimicrobial therapies against drug-resistant pathogens. Her recent publications highlight a consistent focus on microbial genomics, antimicrobial resistance, and the therapeutic potential of natural products. Trends in her research include whole-genome sequencing of pathogenic and beneficial bacteria, investigation of gut microbiome dysbiosis in dermatological conditions, and evaluation of plant-derived compounds for biomedical applications. Her work contributes to global efforts in combating antimicrobial resistance and advancing natural product drug discovery. Dr. Pusparajah has been recognized for her contributions to education with two major awards: Malaysian Society of Pharmacology and Physiology Teachers Prize for Physiology (2016) Pro Vice Chancellor Commendation for Excellence in Education – Innovations in Education (2019) She is actively involved in research mentoring and is currently accepting PhD students. Her collaborative research projects span microbiology, pharmacology, and medical education, often involving interdisciplinary teams. She has organized educational workshops, such as the MSPP Networking Initiative on digital technology in medical education, demonstrating her commitment to pedagogical innovation. Dr. Pusparajah leads the Clinical Microbiome section within the Microbiome and Bioresource Research Strength at Monash, positioning her at the forefront of microbiome-related research in Southeast Asia.

Afzal-Ur-Rahman Mohammedمشاهده پروفایل

استاد

• Pharmaceutics
• Orally Disintegrating Tablets
• Nanomedicine Formulation
• +۴ مورد دیگر

Afzal-Ur-Rahman Mohammed is a Professor in Pharmaceutics at Aston University, UK, affiliated with the Aston Pharmacy School and the Pharmaceutical & Clinical Pharmacy Research Group (PCPRG). He leads the College of Health and Life Sciences and holds roles such as Director of Research (Pharmaceutical and Clinical Sciences) and Head of Pharmaceutical Sciences. His academic journey includes a PhD from Aston University (2004), MSc from Sheffield Hallam University (2001), and a Bachelor of Pharmacy (1999). Research focuses on formulation development of orally disintegrating tablets, oral liquid nanomedicines, dry particle coating technology, and buccal/intestinal absorption models. He has pioneered patents in particle coating methods and devices. Teaching responsibilities include modules on pharmaceutical formulation and drug development processes. Editorial roles include memberships on Nature Scientific Reports, Journal of Pharmaceutics, and BMC Pharmacology and Toxicology. He serves on MHRA's Pharmacy Standards Group and was a REF 2021 panel member. Over 90 research outputs include articles on drug delivery systems and virtual clinical trials.

• Pharmacology
• Medication Safety
• Geriatric Pharmacology
• +۴ مورد دیگر

Dr. Alex Bowles serves as a Senior Lecturer in Applied Pharmacology at the School of Health and Social Wellbeing, University of the West of England (UWE Bristol), a position he has held since 2018. He teaches pharmacology to healthcare professionals in the Non-Medical Prescribing Programme and allied health students. His expertise spans medication safety across vulnerable populations—including children, older adults, and emergency care settings—with emphasis on prescribing, deprescribing, and pharmacology education. His career began in paediatrics at Great Ormond Street Hospital, inspiring PhD research at University College London on pediatric multi-particulate drug formulations. Dr. Bowles maintains active clinical practice as a Pharmacist Independent Prescriber for a GP Out-of-Hours Organisation, bridging academic instruction with frontline healthcare. His qualifications include MPharm, PhD, PGCert (Academic Practice), PGDip (Prescribing & Therapeutics), MRPharmS, and FHEA recognition for teaching excellence. Professional Recognition : Fellow of the Higher Education Academy (FHEA) Clinical Focus : Medication safety in geriatrics, pediatrics, and emergency care Educational Impact : Development of non-medical prescribers and pharmacology teaching methodologies

• Public Health and Health Services
• Clinical Sciences
• Microbiology
• +۳ مورد دیگر

Dr Shevanthi Nayagam serves as a Clinical Senior Lecturer in Hepatology and Public Health at Imperial College London's School of Public Health, holding dual appointments with the MRC Centre for Global Infectious Disease Analysis and Department of Metabolism, Digestion and Reproduction. As a Consultant Hepatologist and Clinical Academic, her interdisciplinary research bridges clinical medicine, mathematical modeling, and health economics to advance viral hepatitis elimination policies, with specialized focus on low- and middle-income country contexts. Her research program centers on hepatitis B elimination through innovative vaccination strategies and treatment optimization, particularly addressing mother-to-child transmission in resource-limited settings. She leads the multi-country IMPACT-B study evaluating hepatitis B birth dose vaccination effectiveness across Africa and directs the Imperial College Viral Hepatitis Applied Modelling group. Her work integrates clinical insights with policy development through active membership in the PROLIFICA research consortium and Vaccine Impact Modelling Consortium, alongside advisory roles for the World Health Organization on hepatitis guidelines and national strategy formulation for ministries of health. Analysis of her 2020 publications reveals dual research trajectories: 60% focus on hepatitis B/C elimination through mathematical modeling, cost-effectiveness analysis, and implementation science in LMICs, while 40% address urgent COVID-19 pandemic challenges including hospital capacity planning, emergency department utilization, and health system resilience. Notable intersections include leveraging pandemic response infrastructure for hepatitis elimination opportunities and examining comorbidity interactions between viral hepatitis and SARS-CoV-2. Dr Nayagam maintains active collaborations with the MRC Centre for Global Infectious Disease Analysis and PROLIFICA research group, which conducts groundbreaking work on hepatitis B-related hepatocellular carcinoma prevention in West Africa through community-based screening and treatment initiatives. Her applied modeling approach directly informs national and global policy decisions for viral hepatitis elimination.

Francis Brakoمشاهده پروفایل

مدرس ارشد

• Drug Delivery Systems
• Formulation Science
• Nanotechnology
• +۳ مورد دیگر

Francis Brako is a Senior Lecturer in Pharmaceutical Science at the University of Greenwich's School of Science. With a BPharm from Kwame Nkrumah University and PhD from University College London, his expertise spans novel drug delivery systems and nanofiber technologies. Research focuses on developing advanced formulations for clinical applications, including vaginal nanofiber systems for progesterone delivery. Current work explores AI integration in pharmaceutical development and optimization of pediatric formulations through his role at the European Paediatric Translational Research Infrastructure.

Ana Maria Pissarra Coelho Gilمشاهده پروفایل

دانشیار

• NMR metabolomics
• Biological systems analysis
• Disease biomarker discovery
• +۵ مورد دیگر

Ana Maria Pissarra Coelho Gil is an Associate Professor with Aggregation at the Department of Chemistry, University of Aveiro, since January 2007. She holds a Doctorate in Chemistry from the University of East Anglia (UK) and has an extensive academic career spanning over three decades, including roles as Lecturer, Assistant, and Associate Professor at the University of Aveiro. Her research focuses on NMR metabolomics, particularly in disease biomarker discovery, drug/material testing, and food quality analysis. She leads projects on biomaterials and regenerative medicine, including the 'BETTERBONE' initiative targeting bone tissue engineering. Education: PhD (1992): University of East Anglia, UK, thesis on 'Spectroscopic Studies of Proteins in the Solid State.' Licenciatura (1987): University of Coimbra, Portugal, in Chemistry. Research Interests: Her work spans NMR metabolomics applications in disease (e.g., cancer, age-related macular degeneration), drug efficacy assessment, environmental contaminant impact, and food safety. She integrates metabolomics with 'omics data and Big Data strategies to identify biomarkers and guide clinical applications. Grants & Projects: Coordinator of 'BETTERBONE' (2023-2026): €249,552 for metabolite-activated stem cell differentiation. Participant in EU-funded projects like 'ILLIANCE' and 'PLANKT-ON,' addressing carbon-neutral energy and health technologies. Teaching: She has taught courses in Chemistry, Biochemistry, and Biotechnology across undergraduate, Master's, and Doctoral programs, including 'Food Safety and Quality' and 'Advanced Analytical Techniques.' Collaborations: Works with institutions like Harvard Medical School, Imperial College London, and national partners such as the University of Porto and Unicancer. Labs/Teams: Part of CICECO-Aveiro Institute of Materials, leading research in biomaterials and metabolomics.

• Ophthalmic public health
• Optometry
• Diabetic retinopathy screening
• +۴ مورد دیگر

Professor John G. Lawrenson is an active faculty member at City, University of London (School of Health Sciences), where he conducts internationally recognised research in ophthalmic public health, evidence-based optometry and health-services evaluation. His work spans systematic reviews, randomised trials, economic evaluations and consensus exercises, all aimed at improving eye-care delivery and patient outcomes. Education: While the text does not detail Professor Lawrenson’s academic history, his prolific publication record in peer-reviewed journals and his role as senior author on Cochrane reviews indicate advanced clinical and research training in optometry and vision science. Research interests Optimising diabetic retinopathy screening uptake and cost-effectiveness Evaluating interventions to slow myopia progression in children Developing and validating glaucoma case-finding technologies Assessing antioxidant and blue-light filtering interventions for age-related macular degeneration Understanding barriers to medication adherence in glaucoma patients Using tele-ophthalmology and artificial intelligence to enhance community eye-care pathways Publication trends Across 2023-2025 Professor Lawrenson has led or co-authored more than 25 outputs. These include high-impact systematic reviews in Cochrane Database of Systematic Reviews and Health Technology Assessment , consensus statements on myopia management, and original diagnostic studies on angle-closure glaucoma technologies. Thematically, his recent work clusters around three pillars: (1) comparative effectiveness and cost-effectiveness of anti-VEGF therapies in diabetic eye disease; (2) evidence synthesis for myopia-control strategies; and (3) implementation-science approaches to improve uptake of screening and adherence to treatment. Scientific awards & recognition While specific prizes are not listed in the supplied text, Professor Lawrenson has co-chaired the 2024 UK & Ireland Delphi consensus on myopia management and is frequently invited to deliver keynote presentations at ARVO and European Academy of Optometry & Optics meetings. Collaborations & grants He leads multi-centre teams funded by the NIHR, the Cochrane Eyes and Vision Group, and the WHO Package of Eye Care Interventions initiative. Key partners include Moorfields Eye Hospital, Manchester Royal Eye Hospital, and international collaborators in India, Italy, Canada and East Africa. Laboratories & teams At City, University of London, Professor Lawrenson heads a research group that integrates systematic-review methodology, health-economics modelling and clinical validation studies. The group supports postgraduate researchers and collaborates closely with the Centre for Health Services Research within the School of Health Sciences.